​
​

Sage Therapeutics Ownership | Who Owns Sage Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Sage Therapeutics Ownership Summary

Sage Therapeutics is owned by 88.88% institutional investors, 11.91% insiders. Vanguard group is the largest institutional shareholder, holding 10.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.31% of its assets in Sage Therapeutics shares.

SAGE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSage Therapeutics88.88%11.91%-0.79%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BB Biotech AG Ord4.46M7.31%-
Fidelity Growth Compy Commingled Pl S2.40M3.93%13.00K
Fidelity Growth Compy Commingled Pl O2.39M3.91%-
Vanguard Total Stock Mkt Idx Inv1.71M2.80%-
SPDR® S&P Biotech ETF1.64M2.69%18.18K
Fidelity Growth Company Fund1.60M2.62%-3.40K
iShares Russell 2000 ETF1.39M2.28%-3.14K
Merchfondo FI950.00K1.55%75.00K
Vanguard Institutional Extnd Mkt Idx Tr841.34K1.38%15.36K
Vanguard Small Cap Index689.95K1.13%1.35K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 09, 2023Barrett Elizabeth-Buy$37.28K
May 09, 2023Barrett Elizabeth-Buy$50.50K
Feb 10, 2023JONAS JEFFREY M-Sell$347.08K
Feb 10, 2023JONAS JEFFREY M-Sell$172.33K
Nov 10, 2022Greene Barry E President and CEOBuy$500.02K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--

SAGE Ownership FAQ

Who Owns Sage Therapeutics?

Sage Therapeutics shareholders are primarily institutional investors at 88.88%, followed by 11.91% insiders and -0.79% retail investors. The average institutional ownership in Sage Therapeutics's industry, Biotech Stocks , is 45.35%, which Sage Therapeutics exceeds.

Who owns the most shares of Sage Therapeutics?

Sage Therapeutics’s largest shareholders are Vanguard group (6.42M shares, 10.67%), Fmr (5.82M shares, 9.68%), and Rtw investments, lp (5.48M shares, 9.11%). Together, they hold 29.47% of Sage Therapeutics’s total shares outstanding.

Does Blackrock own Sage Therapeutics?

Yes, BlackRock owns 8.67% of Sage Therapeutics, totaling 5.22M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 56.64M$. In the last quarter, BlackRock increased its holdings by 323.43K shares, a 6.61% change.

Who is Sage Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Sage Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.27% of its assets in 1.01M Sage Therapeutics shares, valued at 10.98M$.

Who is the top mutual fund holder of Sage Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Sage Therapeutics shares, with 7.31% of its total shares outstanding invested in 4.46M Sage Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools